Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors Treated With Doxorubicin

(MedPage Today) -- A common chemotherapy drug used to treat Hodgkin lymphoma conferred a significantly increased risk of breast cancer among women treated during adolescence and adulthood, a large retrospective study showed. Women who received...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news